Aptamers offer immense potential for the development of unique applications in the field of fundamental research, drug selection, clinical diagnosis, and therapies. They have gained worldwide preference over antibodies owing to the former’s key benefits – greater binding affinity, high specificity, and the ability to not destroy neighboring cells. The major factors driving the aptamers market is growing interest of research scientists in the field of aptamer technology and increasing support from private organizations. On the flip side, lack of knowledge about this technology results in low acceptance. Moreover, ethical issues and inadequate regulatory policies related to aptamer technology threaten to impede the growth of this market.

The worldwide market for aptamers is slated to exhibit an impressive CAGR of 73.1% during the course of the forecast period, rising to a value of US$4.3 bn by 2019.

Growing Application of Aptamers in Therapeutics

Accounting for the leading share by type, nucleic acid aptamers are anticipated to present an opportunity worth US$3.3 bn by 2019, developing at an astounding CAGR of 73.4% during the forecast period. Nucleic acid aptamers have been gaining much traction as a substitute for protein-based targeting approaches. This segment is also projected to be driven by a rising number of leading players collaborating with various organizations and research institutes in order to develop customized nucleic acid aptamers. The introduction of novel selection processes and advanced technology-based aptamers.

On the basis of application, therapeutics is slated to enjoy the dominant share in the aptamers market, registering a strong CAGR of 80.3% during the forecast period to amount to an estimated US$1.4 bn by 2019. The use of aptamers has revolutionized the field of therapeutic development and a number of companies are working toward developing different aptamers for the treatment of a variety of diseases. This is a key factor boosting the uptake of aptamers in therapeutics. Other applications of aptamers include diagnostics and research.

Consistent Collaborations and Investments in R&D to Lend Asia Pacific a Helping Hand

The global market for aptamers is segmented on the basis of geography into Europe, North America, Asia Pacific, and Rest of the World. At the start of the forecast period, North America accounted for more than two-fifth of the overall aptamers market, driven by the strong presence of established companies and growing investments made by them in the field. Europe followed suit, powered by the rising usage of aptamer technologies by small-scale industries. Growth of the aptamers market in this region can also be attributed to consistent efforts and collaborations by players in order to enter the market.

Asia Pacific is projected to witness strong growth by 2019 thanks to impressive investments in R&D, backed by encouraging policies by various governments for the expansion of the pharmaceutical sector. The growing incidence of chronic disorders, such as Alzheimer’s and HIV/AIDS, in APAC has upped the demand for novel therapeutics, which in turn drives the demand for aptamers. Brimming with opportunities in pharmaceutical and diagnostics, the aptamers market in Asia Pacific is sure to attract a lot of attention in the years to come as key players continue to expand and increase product distribution in China, India, and other lucrative countries.

Some of the prominent companies competing in the global aptamers market are Base Pair Biotechnologies, Inc., Vivonics, Inc., SomaLogic Inc., Aptagen, LLC, Aptus Biotech S.L., NeoVentures Biotechnology, Aptamer Solutions Ltd, TriLink BioTechnologies, Inc., AM Biotechnologies, LLC, and Aptamer Sciences, Inc. There is a high degree of rivalry among the key players and this has brought about a surge in investments for the development of novel aptamers.

Aptamers are single standard oligonucleotides that exhibit high specificity and affinity to the variety of target molecules like proteins, bacteria or whole cell. Advancement in aptamer selection technologies which enables to generate high quality of aptamers coupled with efforts of key manufacturer to develop novel aptamers for diagnostics and therapeutics purpose will drive the market growth of global aptamers market. Aptamers technology also plays an important role in the field of biomarker discovery, drug development, analytical chemistry and others. The aptamers market is witnessing tremendous growth worldwide mainly due to various advantages over antibodies such as ease of synthesis and modification, ability to develop improved and cost-effective drugs. In addition, increasing number of scientific research on aptamers further propel the market growth. However, lack of knowledge coupled with ethical hurdles will restrain the market growth of global aptamers market.

The market for aptamers is segmented into by types and by applications. Types segment includes nucleic aptamers and peptide aptamers. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

Aptamers market, by application segment divided into therapeutics development, diagnostics, research and development application and others. This report covers participation of different organizations of the U.S., the U.K. for the development of aptamer field. In addition, it explains various technological advancement and consistent efforts by key players to develop novel aptamers for therapeutic applications. The report includes market estimations of the global aptamers market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global aptamers market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global aptamers market and future opportunities are provided in the aptamers market report. The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global aptamers market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.

Some of the key market players of the global aptamers market include Aptagen, Inc., Aptamer group, Aptamer Sciences, Inc., Somalogic, Inc., “NOXXON Pharma AG,.” and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global aptamers market is segmented into the following categories:

Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables.
...

Hemostasis is the process where platelets, blood vessels, and coagulation factors act together to arrest bleeding. Hemostasis occurs by the coagulation process where blood is solidified from liquid to gel state through serial enzymatic steps.
...